FOIA to SEC for Records Regarding Investigations into Emergent BioSolutions CEO’s Stock Sales

FOIA request to the U.S. Securities and Exchange Commission for documents relevant to any agency investigations into Emergent BioSolutions CEO Robert Kramer’s sale of his company’s stock shortly before its stock prices plummeted because of the contamination of Johnson & Johnson Covid-19 vaccines. SEC-21-0930